Non-Invasive Diagnostic Tests for MASLD in Pediatric Population

Description

This study aims to test the utility of Velacur ultrasound as a non-invasive, rapid, point of care diagnostic tool for detecting the presence and amount of hepatic steatosis in children and adolescents aged 2 - 20 years.

Conditions

Metabolic Dysfunction Associated Steatotic Liver Disease, Non-Alcoholic Fatty Liver Disease (NAFLD)

Talk to us

Study Overview

On this page

Study Details

Study overview

This study aims to test the utility of Velacur ultrasound as a non-invasive, rapid, point of care diagnostic tool for detecting the presence and amount of hepatic steatosis in children and adolescents aged 2 - 20 years.

Non-Invasive Diagnostic Tests for MASLD in Pediatric Population At an Outpatient Clinic: Velacur and Blood-based Novel Tests

Non-Invasive Diagnostic Tests for MASLD in Pediatric Population

Condition
Metabolic Dysfunction Associated Steatotic Liver Disease
Intervention / Treatment

-

Contacts and Locations

Atlanta

Children's Healthcare of Atlanta (CHOA), Atlanta, Georgia, United States, 30322

Atlanta

Emory Children's Center, Atlanta, Georgia, United States, 30322

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Males and females age 2-20 years with suspicion of MASLD or presenting to liver clinic for evaluation of liver disease, including possible MASLD
  • * For participants choosing to do MRI they have to be able to undergo MRI without sedation
  • * Written/verbal informed consent from parent or legal guardian
  • * Written/verbal informed assent from the child when indicated by age
  • * Ascites
  • * Pregnancy
  • * Failure to give consent or assent
  • * Have an implanted electronic device such as pacemaker, neurostimulator, or cochlear implant

Ages Eligible for Study

2 Years to 20 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Emory University,

Miriam Vos, MD, PRINCIPAL_INVESTIGATOR, Emory University

Study Record Dates

2025-01